Delivery Order SPE2DB24D2003-SPE2DB25FXHE7

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,209.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 100 mg tablets, a specialty medication used for the treatment of certain types of epilepsy. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,763.24 firm-fixed-price delivery order is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,493.45, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,013.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets, a prescription medication used to treat epilepsy. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The...
This federal contract award, valued at $3,311.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vimpat 100 mg tablets and has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,161.28 firm fixed-price delivery order is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. The contract has an ultimate completion date of September 21, 2022 and was awarded on September 20, 2022. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the supply of Vimpat 200 mg tablets, a prescription medication used to treat epilepsy, to support military healthcare programs globally. The delivery order has a ceiling value of $2,310.42 and a completion date of December 10, 2024. The contract is a firm fixed-price,...
This federal contract award is a delivery order valued at $1,244.53, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in...
This federal contract award, valued at $2,980.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of Vimpat 100 mg tablets, a prescription medication used to treat epilepsy. This award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.55 firm fixed-price delivery order is for Vimpat 100 mg tablets, a medication used to treat epilepsy. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHE7
    Delivery Order

This federal contract award, valued at $1,229.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets, a medication used to treat certain types of epilepsy. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 9:56 AM